[Multisystem failure: the story of antinfluenza drugs]
- PMID: 24873941
- DOI: 10.1701/1493.16451
[Multisystem failure: the story of antinfluenza drugs]
Abstract
For the past decade decision makers worldwide have endorsed the use of neuraminidase inhibitors. They spent billions of pounds stockpiling the two anti-influenza drugs oseltamivir and zanamivir from the mid-2000s as part of a global effort to be prepared for an influenza pandemic. When the H1N1 pandemic emerged in 2009 the drugs were rolled out around the globe for treatment and prevention of influenza and its complications. Under this spotlight, we were asked to conduct a systematic review for Cochrane to update evidence on their efficacy. What should have been a routine review got complicated as the validity of a key study that underpinned the evidence on efficacy was unclear. Our three and half year battle for data has resulted in the drug manufacturers providing us with full clinical study reports and unveiled a story in which no party has taken full responsibility for ensuring the validity of the evidence underlying its decisions. We hope that the publication of our systematic review of the trials, alongside all the source clinical study reports, will change the way such decisions are made.
Similar articles
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2014 Apr 10;(4):CD008965. doi: 10.1002/14651858.CD008965.pub4 PMID: 22258996 Updated. Review.
-
Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.Health Technol Assess. 2016 May;20(42):1-242. doi: 10.3310/hta20420. Health Technol Assess. 2016. PMID: 27246259 Free PMC article. Review.
-
[Neuraminidase inhibitors: effects still unclear].Dtsch Med Wochenschr. 2012 Oct;137(41):2086. doi: 10.1055/s-0032-1329128. Epub 2012 Oct 2. Dtsch Med Wochenschr. 2012. PMID: 23033163 German. No abstract available.
-
[Influenza A, pregnancy and neuraminidase inhibitors].Med Clin (Barc). 2011 May 28;136(15):688-93. doi: 10.1016/j.medcli.2010.02.006. Epub 2010 Apr 22. Med Clin (Barc). 2011. PMID: 20416906 Review. Spanish.
-
Multisystem failure: the story of anti-influenza drugs.BMJ. 2014 Apr 10;348:g2263. doi: 10.1136/bmj.g2263. BMJ. 2014. PMID: 24721793 No abstract available.
Cited by
-
A SOCS1/3 Antagonist Peptide Protects Mice Against Lethal Infection with Influenza A Virus.Front Immunol. 2015 Nov 11;6:574. doi: 10.3389/fimmu.2015.00574. eCollection 2015. Front Immunol. 2015. PMID: 26617608 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous